pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Preclinical
BIOS: GM I
GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency)
Sylamore Bio
Preclinical
BIOS:MPS I
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Sylamore Bio
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
no indication
LABS JUVISE
← prev
page 67 of 271
next →
Pain
89
Neurology
1
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE)
no indication
Aurobindo Pharma Ltd
Phase 1
BJ-001
Solid Tumor
BJ Bioscience Inc
Phase 1
BJ-005
Solid Tumor
BJ Bioscience Inc
BKEMV
BKEMV (ECULIZUMAB-AEEB)
1 INDICATIONS AND USAGE BKEMV is a complement inhibitor i…
$AMGN
AMGEN INC
Phase 2
BLB-101
Coronavirus Disease 2019 (COVID-19)
Blue Lake Biotechnology Inc
Phase 2
BLB-201
Respiratory Syncytial Virus (RSV) Infections
Blue Lake Biotechnology Inc
BLENREP
BLENREP (BELANTAMAB MAFODOTIN-BLMF)
no indication
GlaxoSmithKline LLC
BLINCYTO
BLINCYTO (BLINATUMOMAB)
1 INDICATIONS AND USAGE BLINCYTO is a bispecific CD19-dir…
$AMGN
AMGEN INC
Phase 1
BLM-11D1
Refractory Acute Myeloid Leukemia
Sichuan Biokin Pharmaceutical Co Ltd
Phase 1
BLM-14D1
Gastrointestinal Tumor
Sichuan Biokin Pharmaceutical Co Ltd
Phase 1
BLM-17D1
Endometrial Cancer
Sichuan Biokin Pharmaceutical Co Ltd
Phase 2
BLU-808
Chronic Inducible Urticaria
Blueprint Medicines Corp
BLUDIGO
BLUDIGO (INDIGOTINDISULFONATE SODIUM)
no indication
PROVEPHARM SAS
BLUJEPA
BLUJEPA (GEPOTIDACIN MESYLATE)
no indication
GlaxoSmithKline LLC
Preclinical
BMD-001
Alzheimer's Disease
Biorchestra Co Ltd
Phase 1
BMF-650
Obesity
$BMEA
Biomea Fusion, Inc.
Phase 2
BMND-08
Alzheimer's Disease
Biomind Labs Inc
Phase 1
BMS-986416
Diffuse Cutaneous Systemic Sclerosis
Bristol-Myers Squibb Co
Phase 2
BMS-986446
Alzheimer's Disease
Bristol-Myers Squibb Co
Phase 1
BMS-986497
Myelodysplastic Syndrome (Preleukemia)
Bristol-Myers Squibb Co
Phase 2
BMX-001
High-Grade Glioma
Biomimetix JV LLC
Phase 2
BNT-111
Metastatic Melanoma
$BNTX
BioNTech SE
Phase 3
BNT-113
Recurrent Head And Neck Squamous Cell Carcinoma
$BNTX
BioNTech SE
Phase 2
BOLD-100
Colorectal Cancer
Bold Therapeutics Inc
Phase 2
BORTEZOMIB
BORTEZOMIB
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Millennium Pharmaceuticals Inc
Phase 2
BOXR-1030
Merkel Cell Carcinoma
SOTIO Biotech AS
Phase 1
BP-1002
Refractory Acute Myeloid Leukemia
$BPTH
BIO-PATH HOLDINGS, INC.
